Appetite Responses to Breakfast Bar Product

January 10, 2025 updated by: General Mills

Appetite Responses to Breakfast Bar Product: a Randomized Controlled Trial

The purpose of this clinical trial is to investigate appetite responses to 2 cereal products in healthy adults.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Minneapolis, Minnesota, United States, 55430
        • Remote

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy adults 18-70 years
  • Habitual snack bar consumers (at least several times per month)
  • Body mass index 18.5-29.9 kg/m2 (based on self-reported weight and height)
  • Understand and willing to follow the study procedures
  • Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial
  • Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day
  • Willing to provide informed consent to participate in the study

Exclusion Criteria:

  • Pregnant or lactating women, or women who are planning to become pregnant during the study
  • Known food allergies, sensitivities, or intolerance to any food or food ingredients
  • Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification
  • Taking medications that affect appetite, metabolism or blood pressure
  • Presence of acute diseases or infection
  • Presence or history of chronic diseases
  • Diagnosed with an eating disorder
  • Restraint eaters as determined by a score >4 from the Dutch Eating Behavior Questionnaire
  • Lost or gained 5 or more pounds in the past 3-months
  • On a weight loss diet or undergoing intermittent fasting
  • COVID-19 infection within the past 3 months
  • Subjects who do not eat bar products

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention (i.e., no food provided)
Experimental: Breakfast Bar
Packaged breakfast bar available in retail stores
Packaged breakfast bar product available in retail stores

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analogue Scale for Hunger 0-240 minutes
Time Frame: 240 minutes
Visual Analogue Scale for "how hungry are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more hunger. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a lower mm change from baseline indicates a better outcome.
240 minutes
Visual Analogue Scale for Fullness 0-240 minutes
Time Frame: 240 minutes
Visual Analogue Scale for "how full are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more fullness. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a higher mm change from baseline indicates a better outcome.
240 minutes
Visual Analogue Scale for Satiation 0-240 minutes
Time Frame: 240 minutes
Visual Analogue Scale for "how satiated are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more satiation. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a higher mm change from baseline indicates a better outcome.
240 minutes
Visual Analogue Scale for Desire to Eat 0-240 minutes
Time Frame: 240 minutes
Visual Analogue Scale for "how strong is your desire to eat right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more desire to eat. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a lower mm change from baseline indicates a better outcome.
240 minutes
Visual Analogue Scale for Prospective Consumption 0-240 minutes
Time Frame: 240 minutes
Visual Analogue Scale for "how much do you think you can eat right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more prospective consumption. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a lower mm change from baseline indicates a better outcome.
240 minutes
Visual Analogue Scale for Satisfaction 0-240 minutes
Time Frame: 240 minutes
Visual Analogue Scale for "how satisfied are you right now?" is scored from 0-100 millimeters (mm), whereby a higher mm indicates more satisfaction. Comparing change from 0 minutes (baseline) to 240 minutes, whereby a higher mm change from baseline indicates a better outcome.
240 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2024

Primary Completion (Actual)

October 24, 2024

Study Completion (Actual)

October 24, 2024

Study Registration Dates

First Submitted

August 21, 2024

First Submitted That Met QC Criteria

August 21, 2024

First Posted (Actual)

August 23, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 10, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 597

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Satisfaction, Consumer

Clinical Trials on Breakfast Bar

Subscribe